ArticleInternational journal of clinical oncology2022

Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study).

Tadahiro Shoji et al.PubMed ↗Publisher ↗

No numbers read from the abstract.